Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
A **defoaming agent** (defoamer, anti-foaming agent) is a chemical additive used primarily to reduce and hinder foam formation in industrial process liquids such as paints, coatings, lubricants, drilling fluids, and crop protection sprays[2][3][5][6]. Defoamers are typically **insoluble** in the foaming medium and possess **surface-active** (surfactant) properties that allow them to disrupt and destabilize foam bubbles, causing them to collapse or merge and thereby reducing surface foam[3][7]. Major chemical classes of defoamers include **silicone-based, oil-based, water-based, and powder formulations**, with specific chemistries tailored for efficacy and compatibility in different industrial systems[5][6][7]. They do not have a direct role in biological signaling pathways and are not classified as molecular therapeutic targets.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Defoaming agent.